URMC / Research / Clinical Trials / Study Details UMMY18121 / Amgen Deno Smol Lipe IIT / Brea LipeResearch Question:Is denosumab, delivered as an injection under the skin, safe and well-tolerated in people with smoldering multiple myeloma? And can denosumab reduce the risk of getting multiple myeloma?Basic Study Information Purpose:This study will assess the safety and tolerability of denosumab in smoldering multiple myeloma subjects as well to see if denosumab can reduce subjects' risk of getting multiple myeloma. Location: University of Rochester Medical CenterStudy Reference #: UMMY18121Lead Researcher (Principal Investigator) Lead Researcher: Brea Lipe Study Contact InformationStudy Coordinator: Jessica MackowiakEmail: jessica_ellis@urmc.rochester.edu Additional Study Details Contact This Study First Name * This field is required Middle Name Last Name * This field is required Phone Number Email I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *You must agree to be contacted to continue. Please call me during the day. Please call me during the evening. Message Thank you for contacting us. People like you are helping URMC make our community and world a healthier place. We sincerely appreciate your effort. A member of our research team will be in touch with you. URMC / Wilmot Cancer Institute /Research / Clinical Trials / Study Details Trial Not Found The study you are looking for is not active at this time. Return to Search